Get the Stockscreener App
0.6949
0.27%
-0.0019
After Hours:
.72
0.0251
+3.61%
VolitionRX Ltd Stock (VNRX) Forecast
The VolitionRX Ltd (VNRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.4953, representing a +259.09% increase from the current price of $0.6949. The highest analyst price target is $3.0267, and the lowest is $1.964.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VNRX Price Target
Average 1.5737
(+126.47% Upside)
Is VolitionRX Ltd (VNRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.28 | Neutral |
| STOCH(9,6) | 48.03 | Neutral |
| STOCHRSI(14) | 7.5387 | Buy |
| MACD(12,26) | 0.0116 | Sell |
| ADX(14) | 16.85 | Neutral |
| William %R | -65.95 | Neutral |
| CCI(14) | -52.70 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.721
Sell
|
0.7142
Sell
|
| MA20 |
0.6955
Sell
|
0.7057
Sell
|
| MA50 |
0.6874
Buy
|
0.6906
Buy
|
| MA100 |
0.669
Buy
|
0.6919
Buy
|
| MA200 |
0.7264
Sell
|
0.7369
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, VNRX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on VNRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.28 indicates that VNRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.03 indicates that VNRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.5387 indicates that VNRX is oversold. This suggests that VNRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.85 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -52.7 indicates that VNRX is still oversold but not to an extreme extent.
Long-term VNRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about VolitionRX Ltd financial reports and earnings history, VolitionRX Ltd (VNRX) stock could reach $1.7884 by 2030, $1.3539 by 2040 and $4.5615 by 2050. See the projected annual prices until 2050 of the VolitionRX Ltd stock below:
- VolitionRX Ltd (VNRX) is expected to reach an average price of $0.8972 in 2035, with a high prediction of $0.8703 and a low estimate of $0.8923. This indicates an $29.11% rise from the last recorded price of $0.6949.
- VolitionRX Ltd (VNRX) stock is projected to chart a bullish course in 2040, with an average price target of $1.4049, representing an $102.18% surge from its current level. The forecast ranges from a conservative $1.4018 to a sky-high $1.3539.
- Our analysts predict VolitionRX Ltd (VNRX) to jump 392.72% by 2045, soaring from $3.3997 to an average price of $3.4239, potentially reaching $3.4292. While $3.3997 is the low estimate, the potential upside is significant.
- VolitionRX Ltd (VNRX) stock is expected to climb by 2050, reaching an average of $4.5099, a $549.00% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.5615 and $4.5547, respectively, highlighting the market's uncertainty.
VolitionRX Ltd Stock (VNRX) Year by Year Forecast
VolitionRX Ltd Stock (VNRX) Price Forecast for 2025
VolitionRX Ltd Stock (VNRX) is expected to reach an average price of $1.5737 in 2025, with a high prediction of $3.1125 and a low estimate of $0.035. This indicates an +126.47% rise from the last recorded price of $0.6949.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.5393 | $1.964 | $3.0267 | +265.42% |
| February, 2025 | $2.5744 | $2.3646 | $2.9256 | +270.47% |
| March, 2025 | $1.1298 | $0.8098 | $2.9735 | +62.59% |
| April, 2025 | $0.8364 | $0.035 | $2.1162 | +20.37% |
| May, 2025 | $1.6367 | $0.8277 | $1.6967 | +135.53% |
| June, 2025 | $1.512 | $1.512 | $2.3605 | +117.58% |
| July, 2025 | $1.5936 | $0.6583 | $1.7286 | +129.32% |
| August, 2025 | $1.4188 | $1.0988 | $2.1599 | +104.18% |
| September, 2025 | $1.2941 | $1.0777 | $3.1125 | +86.23% |
| October, 2025 | $1.1957 | $1.0757 | $1.6067 | +72.07% |
| November, 2025 | $1.251 | $0.9347 | $1.361 | +80.02% |
| December, 2025 | $1.0326 | $0.9426 | $1.8399 | +48.59% |
VolitionRX Ltd Stock (VNRX) Price Forecast for 2026
The predicted value for VolitionRX Ltd (VNRX) in 2026 is set at an average of $2.8563. Estimates vary from a peak of $4.8137 to a trough of $0.8989, indicating an +311.03% surge from the present price of $0.6949.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.4478 | $0.8989 | $1.7415 | +108.35% |
| February, 2026 | $2.1531 | $1.2942 | $2.1931 | +209.84% |
| March, 2026 | $2.1284 | $1.4221 | $2.5894 | +206.29% |
| April, 2026 | $3.02 | $2.0947 | $4.8137 | +334.59% |
| May, 2026 | $1.6252 | $1.5952 | $3.0663 | +133.88% |
| June, 2026 | $1.7905 | $1.4279 | $2.4716 | +157.67% |
| July, 2026 | $1.6421 | $1.1922 | $1.8318 | +136.31% |
| August, 2026 | $1.8074 | $1.6184 | $2.2063 | +160.09% |
| September, 2026 | $1.409 | $1.249 | $1.8037 | +102.76% |
| October, 2026 | $1.4742 | $1.2179 | $1.7167 | +112.15% |
| November, 2026 | $1.6395 | $1.2306 | $1.8006 | +135.94% |
| December, 2026 | $1.4711 | $1.3911 | $1.8458 | +111.70% |
VolitionRX Ltd Stock (VNRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for VolitionRX Ltd (VNRX) is $1.5525, with a high forecast of $2.5618 and a low forecast of $0.5433. This indicates an +123.42% increase from the last price of $0.6949.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.7564 | $1.3437 | $2.1264 | +152.75% |
| February, 2027 | $2.3117 | $1.5727 | $2.5618 | +232.66% |
| March, 2027 | $1.8532 | $1.5106 | $2.3605 | +166.69% |
| April, 2027 | $1.4985 | $1.4785 | $1.9096 | +115.65% |
| May, 2027 | $1.2338 | $0.8712 | $1.5508 | +77.55% |
| June, 2027 | $1.1754 | $1.1101 | $1.6001 | +69.14% |
| July, 2027 | $1.5707 | $0.938 | $1.8607 | +126.03% |
| August, 2027 | $1.2759 | $1.2359 | $1.717 | +83.61% |
| September, 2027 | $1.0975 | $0.6849 | $1.5386 | +57.94% |
| October, 2027 | $0.6828 | $0.5928 | $1.3138 | -1.74% |
| November, 2027 | $1.0481 | $0.6491 | $1.0481 | +50.82% |
| December, 2027 | $0.7497 | $0.5433 | $1.0744 | +7.88% |
VolitionRX Ltd Stock (VNRX) Price Forecast for 2028
In 2028, VolitionRX Ltd (VNRX) is projected to reach an average price of $0.8194, with a high projection of $1.5786 and a low estimate of $0.0602. This indicates an +17.91% rise from the last price of $0.6949.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3749 | $0.2523 | $0.756 | -46.05% |
| February, 2028 | $0.1102 | $0.0602 | $0.5376 | -84.14% |
| March, 2028 | $0.7718 | $0.0865 | $0.9218 | +11.07% |
| April, 2028 | $1.1171 | $0.4244 | $1.1871 | +60.75% |
| May, 2028 | $1.2887 | $0.7123 | $1.5786 | +85.45% |
| June, 2028 | $1.4639 | $1.065 | $1.5638 | +110.67% |
| July, 2028 | $0.6092 | $0.5012 | $1.5702 | -12.33% |
| August, 2028 | $0.7508 | $0.5555 | $0.9955 | +8.04% |
| September, 2028 | $0.7361 | $0.3671 | $0.8997 | +5.92% |
| October, 2028 | $0.9713 | $0.5087 | $1.0713 | +39.78% |
| November, 2028 | $0.5429 | $0.3766 | $1.0476 | -21.87% |
| December, 2028 | $0.4182 | $0.3882 | $0.8056 | -39.82% |
VolitionRX Ltd Stock (VNRX) Price Forecast for 2029
The 2029 price forecast for VolitionRX Ltd Stock (VNRX) is $0.8159 on average, with a high prediction of $1.6216 and a low estimate of $0.0102. This represents an +17.41% increase from the previous price of $0.6949.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.3998 | $0.2608 | $0.5972 | -42.47% |
| February, 2029 | $0.3151 | $0.1987 | $0.4661 | -54.66% |
| March, 2029 | $0.3303 | $0.2782 | $0.4903 | -52.46% |
| April, 2029 | $0.2044 | $0.2037 | $0.3167 | -70.59% |
| May, 2029 | $0.0471 | $0.0595 | $0.1419 | -93.22% |
| June, 2029 | $0.0799 | $0.0628 | $0.0634 | -88.50% |
| July, 2029 | $0.0652 | $0.1686 | $0.0712 | -90.61% |
| August, 2029 | $0.3093 | $0.0124 | $0.4141 | -55.48% |
| September, 2029 | $0.3146 | $0.1946 | $0.492 | -54.73% |
| October, 2029 | $0.0389 | $0.0262 | $0.3999 | -94.40% |
| November, 2029 | $0.0525 | $0.0102 | $0.1545 | -92.44% |
| December, 2029 | $1.6348 | $0.0712 | $1.6216 | +135.26% |
VolitionRX Ltd Stock (VNRX) Price Forecast for 2030
VolitionRX Ltd Stock (VNRX) is expected to reach an average price of $1.0539 in 2030, with a high forecast of $2.1038 and a low forecast of $0.00399. This signifies an +51.66% surge from the last price of $0.6949.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.9211 | $1.7478 | $1.7884 | +176.46% |
| February, 2030 | $1.4879 | $1.8905 | $1.6958 | +114.11% |
| March, 2030 | $0.6973 | $0.7473 | $1.2752 | +0.35% |
| April, 2030 | $1.1868 | $0.9494 | $0.7068 | +70.78% |
| May, 2030 | $1.0034 | $0.4662 | $2.1038 | +44.39% |
| June, 2030 | $1.3167 | $0.2743 | $1.4969 | +89.49% |
| July, 2030 | $0.6001 | $0.4449 | $1.3996 | -13.64% |
| August, 2030 | $0.1706 | $0.2393 | $0.7928 | -75.45% |
| September, 2030 | $0.4112 | $0.00399 | $0.7533 | -40.82% |
| October, 2030 | $0.4594 | $0.0044 | $0.5544 | -33.89% |
| November, 2030 | $1.4901 | $0.127 | $0.7851 | +114.43% |
| December, 2030 | $1.2107 | $1.3445 | $1.2124 | +74.23% |
0.41%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):